Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Hayri Karaaslan"'
Publikováno v:
Advances in Therapy. 23:769-771
The case of a 46-year-old woman with chronic hepatitis C who was prescribed subcutaneous pegylated interferon once a week and oral ribavirin once a day is presented. Within 24 h after the first injection to her left arm, the patient developed pruritu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::23027313e773eb80c33d159b0270c438
https://doi.org/10.1007/bf02850316
https://doi.org/10.1007/bf02850316
Autor:
Cihan Yurdaydin, Ozden Uzunalimoglu, Kendal Yalcin, Meral Akdogan, Hakan Senturk, Esra Erden, Hayri Karaaslan, Ö. Erkan-Esin, A.M. Bozdayi, Hülya Çetinkaya, Fatih Oğuz Önder, J. L. Gerin, Ali Özden, Raymond F. Schinazi, Hakan Bozkaya
Publikováno v:
Journal of viral hepatitis. 15(4)
SUMMARY. Chronic delta hepatitis is the most severe form of chronic viral hepatitis for which interferon (IFN) is the only available treatment. In 39 patients (25 were treatment-nao ¨ve, 14 had previously used IFN), efficacy of 1-year treatment with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a74deeda2f17f0423e8db33e0cd2d5b5
https://pubmed.ncbi.nlm.nih.gov/18307594
https://pubmed.ncbi.nlm.nih.gov/18307594
Autor:
Ozlem Erkan, Kendal Yalcin, Hayri Karaaslan, Fatih Oğuz Önder, Cihan Yurdaydin, Ozden Uzunalimoglu, Hakan Bozkaya, Halil Degertekin, A.M. Bozdayi
Publikováno v:
Journal of viral hepatitis. 14(11)
High dose interferon treatment for 1 year is the only established treatment for chronic hepatitis D, but it is associated with a high relapse rate after treatment discontinuation. In this study, patients were treated with 10 MU interferon alpha 2b, t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6422e34e56eee84962e20749495997c9
https://pubmed.ncbi.nlm.nih.gov/17927618
https://pubmed.ncbi.nlm.nih.gov/17927618
Autor:
Hayri Karaaslan, Handan Kayhan, A. Mithat Bozdayi, Cihan Yurdaydin, Ersin Karatayli, A. Resat Türkyilmaz, Selim Karayalcin, Fikret Sahin
Publikováno v:
ResearcherID
Europe PubMed Central
Scopus-Elsevier
Europe PubMed Central
Scopus-Elsevier
AimsThis study was conducted to clarify the resistance profile of a novel mutation pattern emerging during lamivudine (3TC) therapy and showing cross-resistance to adefovir dipivoxil (ADV) in a patient with chronic hepatitis B.Methods and resultsSucc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::836e8d78ced4248eca70e0440d223b3d
https://pubmed.ncbi.nlm.nih.gov/17713159
https://pubmed.ncbi.nlm.nih.gov/17713159
A splenic hydatid cyst is a rare clinical entity from among abdominal hydatid cysts, even in endemic countries. Here, a case with lumbar pain due to a giant splenic hydatid cyst is presented. The importance of this case is that the patient presented
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8305ccb95342bd63e1807e09cb021d17
http://hdl.handle.net/20.500.12645/23645
http://hdl.handle.net/20.500.12645/23645
